Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study
Uncontrolled asthma in growing children can impair lung growth that may lead to adverse complications in later life. Dupilumab, a human monoclonal antibody, blocks the shared receptor for IL-4 and IL-13, key drivers of type 2 inflammation.